Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Quick Links

Call customer care

TheraSphere mechanism of action explained

TheraSphere Y-90 glass microspheres are uniquely engineered to have unmatched radiation per microsphere (RPM). This allows TheraSphere to maximize repetitive and cumulative radiation exposure to tumor cells to achieve complete pathological necrosis (CPN) at ablative doses. With data since 1999 that spans the BCLC algorithm, TheraSphere is the only FDA approved Y-90 therapy for HCC and is backed by positive level 1 clinical evidence.